NATURE.COM
NEWS@NATURE.COM
NATUREJOBS
NATUREEVENTS
ABOUT NPG
Help
Nature.com site index
SEARCH
Advanced search
Research Highlight
doi:10.1038/ncpendmet0057
Should muraglitazar be approved by the FDA for the treatment of type 2 diabetes?
Rebecca Doherty
This article appears in:
Nature Clinical Practice Endocrinology & Metabolism
2, 62 (01 February 2006)
Nature Clinical Practice Cardiovascular Medicine
3, 123 (01 March 2006)
© 2008 Nature Publishing Group
|
Privacy policy